Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Oncternal Therapeutics to Present at Stifel Healthcare Conference


Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that James Breitmeyer, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the Stifel 2019 Healthcare Conference in New York City on Tuesday, November 19, 2019 at 10:20 a.m. ET / 7:20 a.m. PT.

A live webcast of the presentation will be available online via a link from the investor relations page of the Company's website at www.oncternal.com, and the webcast will be archived there for at least 30 days following the event.

About Oncternal Therapeutics

Oncternal Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer generation or progression. The pipeline includes cirmtuzumab, an investigational monoclonal antibody designed to inhibit the ROR1 pathway, a type I tyrosine kinase-like orphan receptor, that is being evaluated in a Phase 1/2 clinical trial in combination with ibrutinib for the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), and TK216, an investigational small-molecule compound that is designed to inhibit E26 transformation specific (ETS) family oncoproteins, that is being evaluated in a Phase 1 clinical trial for patients with Ewing sarcoma alone and in combination with vincristine chemotherapy. In addition, Oncternal has a program to develop a CAR-T therapy that targets ROR1, which is currently in preclinical development as a potential treatment for hematologic cancers and solid tumors. More information is available at www.oncternal.com.


These press releases may also interest you

at 05:30
Solis Health Plans, a Medicare Advantage Plan, is pleased to join the effort to bring COVID-19 testing to South Florida senior citizens. Under the leadership of Former State Senator Rene Garcia and Miami-Dade County Commissioner Esteban Bovo, Solis...

3 avr 2020
One-day mobile collections for COVID-19 testing specimens are continuing this weekend and into early next week, with the University of Mississippi Medical Center, Mississippi State Department of Health, Mississippi Emergency Management Agency and...

3 avr 2020
Cheeriodicals today announced the delivery of more than 200 personalized cheer-up gifts to pediatric patients at Cottage Children's Medical Center and to Veteran patients at Santa Barbara Veterans Affairs Clinic.  Cheeriodicals' gifts are made up of...

3 avr 2020
Kaiser Permanente has announced that it will waive all member out-of-pocket costs for inpatient and outpatient services related to the treatment of COVID-19, as of April 1, 2020. This is intended to alleviate the cost burden and stress on impacted...

3 avr 2020
The management of Olymel deplores the untruthful and irresponsible information that an anonymous person circulated on social networks on Friday April 3 to the effect that products from his pork processing facility in Yamachiche could transmit the...

3 avr 2020
As more states are ordering businesses to temporarily close and millions of residents to stay at home because of the coronavirus, Rx relief, a division of PrideStaff, is proud to partner with essential businesses and healthcare organizations, helping...



News published on 11 november 2019 at 08:05 and distributed by: